Beta blockers and cirrhosis, 2016
- 1 January 2017
- journal article
- review article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 49 (1) , 3-10
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Propranolol use beyond 6 months increases mortality in patients with Child‐Pugh C cirrhosis and ascitesHepatology, 2016
- Development of hyperdynamic circulation and response to β‐blockers in compensated cirrhosis with portal hypertensionHepatology, 2015
- Expanding consensus in portal hypertensionJournal of Hepatology, 2015
- UK guidelines on the management of variceal haemorrhage in cirrhotic patientsGut, 2015
- Nonselective beta-blockers in cirrhotic patients with no or small varices: A meta-analysisWorld Journal of Gastroenterology, 2015
- Noninvasive screening for liver fibrosis and portal hypertension by transient elastography—a large single center experienceWiener klinische Wochenschrift, 2012
- Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trialHepatology International, 2012
- Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosisHepatology, 2007
- Beta-Blockers to Prevent Gastroesophageal Varices in Patients with CirrhosisNew England Journal of Medicine, 2005
- A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosisGastroenterology, 2004